Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.27.691010

Fine-Tuning Protein Language Models Enhances the Identification and Interpretation of the Transcription Factors

Abstract

Transcription factors (TFs) are pivotal regulators of gene expression and play essential roles in diverse cellular activities. The three-dimensional organization of the genome and transcriptional regulation are predominantly orchestrated by TFs. By recruiting the transcriptional machinery to gene enhancers or promoters, TFs can either activate or repress transcription, thereby controlling gene activity and various biological pathways. Accurate identification of TFs is vital for elucidating gene regulatory mechanisms within cells. However, experimental identification remains labor-intensive and time-consuming, highlighting the necessity for efficient computational approaches. In this study, we present a two-layer predictive framework utilizing protein language models (pLMs) via full fine-tuning and parameter-efficient fine-tuning. The initial layer robustly classifies and identifies transcription factors, while the subsequent layer predicts TFs with a binding preference for methylated DNA (TFPMs). Our approach further incorporates attention weights and protein sequence motifs to enhance interpretability and predictive capability. By leveraging attention mechanisms, we highlight biologically relevant regions of the protein sequences that contribute most strongly to the predictions. Additionally, motif analysis facilitates the identification of conserved sequence patterns that are critical for TF recognition and function. Across both TF and TFPM classification tasks, the inclusion of these features allowed our methods to consistently surpass contemporary models, as demonstrated by independent test results. KeypointsO_LIDeveloped a two-layer predictive framework using protein language models (pLMs) with both full fine-tuning and parameter-efficient fine-tuning methods. C_LIO_LIThe first layer accurately identifies transcription factors (TFs), and the second layer predicts TFs with binding preference for methylated DNA (TFPMs). C_LIO_LIIntegrated attention weights and protein sequence motifs to enhance model interpretability by highlighting biologically relevant sequence regions and conserved patterns. C_LIO_LIAchieved superior performance compared to state-of-the-art methods, validated by independent testing. C_LI Mir Tanveerul Hassan obtained his M.Tech. in Computer Science from the University of Kashmir, India, in 2020, and later earned his Ph.D. in Electronics and Information Engineering from Jeonbuk National University, Jeonju, South Korea. He is currently serving as a postdoctoral fellow at the Jeonbuk RICE Intelligence Innovation Research Center. His research interests encompass computational biology, bioinformatics, and pattern recognition. Saima Gaffar received her B.Tech. and M.Tech. degrees in Computer Science from the University of Kashmir, Srinagar, India, and her Ph.D. in Electronics and Information Engineering from Jeonbuk National University, South Korea. Her research focuses on bioinformatics, computational biology, deep learning, and image processing. Hamza Zahid received his B.S. degree in Mechatronics Engineering from the University of Engineering and Technology, Peshawar, Pakistan. He is currently pursuing the integrated M.S. and Ph.D. degrees in Electronics and Information Engineering at Jeonbuk National University, South Korea. His primary research interests include the applications of artificial intelligence in computational drug discovery. Sang Jun Lee received his B.S., M.S., and Ph.D. degrees in Electrical Engineering from POSTECH, South Korea. Following his doctoral studies, he worked as a senior researcher at the Samsung Advanced Institute of Technology (SAIT). He is currently an Associate Professor in the Division of Electronics and Information Engineering at Jeonbuk National University, South Korea. His research interests include image analysis, deep learning, and medical image processing.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hassan, M. T., Gaffar, S., Zahid, H., Lee, S. J.. 2025-11-28. Fine-Tuning Protein Language Models Enhances the Identification and Interpretation of the Transcription Factors. https://doi.org/10.1101/2025.11.27.691010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale studies. In addition, existing computational approaches often struggle to effectively integrate heterogeneous biomedical data, capture the complex higher-order topological signatures of biological interactomes, and generalize to unseen entities. Here, we present HANAMI (Heterogeneous grAph coNtrastive leArning for drug-gene-disease Motif predIction), a multi-view deep graph learning framework designed to model complex interactions among drugs, genes, and diseases. HANAMI integrates diverse heterogeneous biomedical knowledge, including chemical structures, genomic sequences, and clinical phenotypes, and leverages relation-aware topology encoding, structure-aware aggregation, and contrastive learning to enable accurate motif prediction with biological context from the network. Systematic evaluation on benchmark datasets shows that HANAMI achieves up to 6% improvements over existing state-of-the-art methods in predicting drug-gene-disease motifs. The framework further demonstrates strong inductive generalization, maintaining an [~]18% performance advantage in zero-shot settings involving previously unseen entities. Beyond predictive performance, HANAMI effectively prioritizes drug-disease relationships investigated in Phase II or III trials while identifying candidate genes that suggest plausible mechanistic links. Together, HANAMI provides a computational framework for interpreting complex biomedical interactions, offering a scalable foundation to accelerate drug repurposing and therapeutic innovation.

bioinformatics↗

PTMExplorer: A Multi-Dimensional Integrative Visualization Platform for Protein Post-Translational Modification Function and Structure

Deciphering the functions of post-translational modifications (PTMs) is a critical bridge connecting large-scale modification proteomics data to mechanistic studies. However, most existing tools for visualizing PTM omics data are limited to site catalogs or single-dimensional feature displays. They lack the capability to simultaneously map user-derived differential modification sites onto multi-dimensional contexts, including protein three-dimensional (3D) structure, evolutionary conservation, functional sites, and disease associations. This limitation makes it difficult for researchers to rapidly assess the biological importance of candidate sites from among a vast number of differentially modified sites. Here, we present PTMExplorer, an interactive platform for the multi-dimensional visualization of protein PTMs. PTMExplorer comprises three core modules: PTM Inspector, built upon ProtVista, provides a multi-track, sequence-feature integrated view incorporating intrinsically disordered region (IDR) prediction (via flDPnn), surface accessibility calculation (via FreeSASA), and UniProt functional annotations; PTM 3D Locator, leveraging the Nightingale/Mol* engine, anchors modification sites onto AlphaFold/Protein Data Bank (PDB) 3D structures through residue mapping via PDBe-SIFTS; and PTM Overview, utilizing the R circlize package, presents a panoramic polar circos plot illustrating modification distribution and inter-group differential regulation. Additionally, three major disease-associated modification databases (PTMD, qPTM, and PhosCancer) are integrated as PTM-Disease Nexus, enabling co-localization comparison between user-defined differential sites and reported disease-related sites. PTMExplorer currently supports eight model organisms, accepts user-uploaded differential analysis results, and provides multi-dimensional annotations and various visualization options (https://www.bioladder.cn/PTMExplorer/). Using a multi-omics dataset from hepatocellular carcinoma (18 patients, 9 modification types) as a case study, we demonstrate the practical utility of PTMExplorer in screening potential biomarkers, revealing multi-modification coordination mechanisms, and distinguishing between absolute and relative quantification patterns.

bioinformatics↗

Integrative analysis of the MDM2 promoter switch and cellular lineage plasticity in colorectal cancer: a contrast between the autonomous-proliferation type (CIN/CMS2) and the environment-adaptive type (MSI/gastric metaplasia)

Background: Biomarkers that stratify colorectal cancer (CRC) by therapeutic responsiveness and are measurable directly in biopsy specimens remain insufficiently established. We investigated whether usage of the dual MDM2 promoters (P1/P2) acts as a molecular switch separating two diametrically opposed CRC phenotypes: a chromosomal instability type and an environment adaptive type (microsatellite instability/serrated pathway with gastric metaplasia). Methods: Sixty three organoid samples from 22 patients with CRC were classified morphologically by deep learning (VGG16) and molecularly by an MDM2 Splicing Index derived from expression arrays. The P1 and P2 signatures (gene sets characterizing P1 and P2dominant samples) were externally validated in TCGA-COAD/READ (n = 624) and GSE39582 (n = 536), 1,160 cases in total, and therapeutic implications were tested in public cell line panels (GDSC2, DepMap) and in 65 lines of an independent patient derived CRC organoid biobank. Results: Deep learning morphological classification reached 98.5% test accuracy (64/65), and morphology corresponded to P1/P2 isoform usage: Type1 (compact glandular) morphology predominated in P1 dominant samples (median Type1 fraction 0.826 versus 0.444) and non Type1 (cystic mucinous) morphology in P2 dominant samples (AUC 0.79). Both signatures differed across the four consensus molecular subtypes , and the P2 signature was higher in mismatch repair deficient (microsatellite-unstable) tumors. Promoter usage quantified directly (P2_index) was higher in TP53 wild type tumors , consistent with P2 being p53-inducible. TP53 wild type cell lines were more sensitive to the MDM2 inhibitor Nutlin 3a and were more dependent on MDM2 in the DepMap CRISPR screen ; among 198 GDSC2 drugs, Nutlin 3a correlated most strongly with the P2 score. In the independent biobank, TP53 wild type lines (17) were more sensitive to nutlin-3 than mutant lines (48) (median log(IC50) 1.386 versus 4.283). Conclusions: MDM2 promoter choice (P1/P2) co-varies with the lineage identity of cancer cells and with the secretory, mucin rich character of the tumor tissue, consistent with a molecular-switch role alongside p53 suppression. The MDM2 P1/P2 ratio, measurable by RT qPCR or targeted NGS, is a candidate molecular-classification and therapeutic-stratification biomarker corresponding robustly to CMS, MSI, and TP53 mutation status.

bioinformatics↗